24 November 2012 | Analysis | By BioSpectrum Bureau
4th Annual BioSpectrum-CMR Survey' of contract and clinical research organizations (CRO) 2012
Addressing Accessibility an...
Can Test, Treat, Track Beat...
“AI will be integrally invo...
How Indian Biotech Investme...
“We anticipate India will adopt dec
“Because of its specificity and sel
Samsung Biologics signs MoU with Se
Kimer Med inks contract worth NZD $
Queensland's Southern RNA joins for
US FDA clears Beckman Coulter Life
Is the APAC region addressing accessibility and affordability of cell & gene therapies?